ACCESS Newswire

    / Wellgistics Health, Inc. (“Wellgistics” or the “Company”) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent (“LOI”) to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.

    / PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s

    Editor's Pick

    Comprehensive technical audits have confirmed that Dubai-headquartered enterprise digital publishing platform Integrated Identity has recorded validated 100/100 scores across both mobile and desktop environments on Google PageSpeed Insights. Backed by data from the HTTP Archive and the Chrome User Experience